ArticleTranslational andrology and urology2020

Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?

Sławomir Poletajew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.